- Delivering Pan India
Darzalex® (Daratumumab) Daratumumab 100 mg/5 mL and 400 mg/20 mL IV infusion by Janssen (Johnson & Johnson). Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Daratumumab 100 mg/5 mL, 400 mg/20 mL |
|---|---|
| Manufacturer | Janssen (Johnson & Johnson) |
| Country | Belgium |
| Pack size | 1 vial |
| Storage | Store refrigerated at 2°C to 8°C in the original carton, as stated on the label |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Darzalex® (Daratumumab) 100 mg/5 mL and 400 mg/20 mL Concentrate for IV Infusion: A Sourcing Guide for Hospitals and Pharmacies
Darzalex® is a daratumumab injection (CD38-directed monoclonal antibody) marketed by Janssen, a Johnson & Johnson company. The decision to prescribe daratumumab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Darzalex® (daratumumab) 100 mg/5 mL and 400 mg/20 mL concentrate for intravenous infusion to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Cancer category. Supply is in bulk/wholesale quantities only.
Darzalex contains daratumumab, a human monoclonal antibody supplied as a concentrate for intravenous infusion in single-dose vials of 100 mg/5 mL and 400 mg/20 mL, prepared and administered by healthcare professionals. A separate subcutaneous co-formulation with hyaluronidase is marketed in some regions as Darzalex Faspro. Presentations marketed in India are those on the Indian pack.
How it works, according to the label: The US prescribing information (DailyMed) describes daratumumab as a CD38-directed cytolytic antibody.
The current US prescribing information for Darzalex (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Darzalex pack insert.
Published studies of daratumumab include CASTOR (N Engl J Med 2016) and POLLUX (N Engl J Med 2016) in relapsed or refractory multiple myeloma, ALCYONE (N Engl J Med 2018) and MAIA (N Engl J Med 2019) in newly diagnosed multiple myeloma. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Daratumumab 100 mg/5 mL | Concentrate for solution for IV infusion | Single-dose vial (confirm against the carton) |
| Daratumumab 400 mg/20 mL | Concentrate for solution for IV infusion | Single-dose vial (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, oncology and haematology centres, day-care infusion units and pharmacies in India that need to source Darzalex in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. Refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store refrigerated at 2°C to 8°C in the original carton, protected from light, as directed on the pack. Do not freeze or shake.
Darzalex is marketed by Janssen, a Johnson & Johnson company. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Darzalex through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Darzalex available in India?
A.K. Pharma supplies Darzalex® (daratumumab) 100 mg/5 mL and 400 mg/20 mL concentrate for intravenous infusion to hospitals and pharmacies in India. Contact us for current availability.
What does Darzalex contain?
Darzalex contains daratumumab, marketed by Janssen (Johnson & Johnson). The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
